Renin–angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs
Luis M Ruilope, Juan Tamargo, Gema Ruiz‐Hurtado
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)PandemicRenin–angiotensin system2019-20 coronavirus outbreakPharmacologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyInternal medicineBlood pressureDiseaseOutbreakInfectious disease (medical specialty)COVID-19 Clinical Research StudiesBlood Pressure and Hypertension StudiesCOVID-19 and healthcare impacts